Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders.
Dutan Polit L, Eidhof I, McNeill RV, Warre-Cornish KM, Yde Ohki CM, Walter NM, Sala C, Verpelli C, Radtke F, Galderisi S, Mucci A, Collo G, Edenhofer F, Castrén ML, Réthelyi JM, Ejlersen M, Hohmann SS, Ilieva MS, Lukjanska R, Matuleviciute R, Michel TM, de Vrij FMS, Kushner SA, Lendemeijer B, Kittel-Schneider S, Ziegler GC, Gruber-Schoffnegger D, Pasterkamp RJ, Kasri A, Potier MC, Knoblich JA, Brüstle O, Peitz M, Pich EM, Harwood AJ, Abranches E, Falk A, Vernon AC, Grünblatt E, Srivastava DP.
Dutan Polit L, et al. Among authors: ziegler gc.
Neurosci Appl. 2023 Mar 20;2:101125. doi: 10.1016/j.nsa.2023.101125. eCollection 2023.
Neurosci Appl. 2023.
PMID: 40655966
Free PMC article.
Review.